[Prevention and treatment of fungal infections in solid-organ transplant recipients].
Muñoz
P
P
Servicio de Microbiología Clínica-Enfermedades Infecciosas, Hospital Universitario Gregorio Marañón, Madrid.
Bouza
E
E
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015725:Fluconazole / Q000627:therapeutic use; D016027:Heart Transplantation; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D007654:Ketoconazole / Q000627:therapeutic use; D016030:Kidney Transplantation; D016031:Liver Transplantation; D016040:Lung Transplantation; D015337:Multicenter Studies as Topic; D009181:Mycoses / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D016035:Pancreas Transplantation; D012307:Risk Factors; D014180:Transplantation
D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D007654:Ketoconazole